BRCA2 and breast carcinoma: However, further analysis of a significant number of BRCA1 and BRCA2 missense variants of uncertain significance (VUS) continue to pose an important obstacle to the clinical management of a considerable portion of familial breast cancer probands and families who carry such VUS.